NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Liabilities and Shareholders Equity (2018 - 2026)

Updated

NextCure (NXTC) posted Liabilities and Shareholders Equity of $9.7 million for Q3 2026, down 75.5% from $39.61 million a year earlier and down 57.1% from the prior quarter.

Analysis

NextCure (NXTC) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, NextCure's Liabilities and Shareholders Equity came in at $50.18 million, down 37.9% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for six consecutive years, with a five-year compound annual growth rate of -30.4% (FY2020 to FY2025).
  • In prior years, NextCure's Liabilities and Shareholders Equity was $80.86 million in FY2024 (-36.8%), $128.04 million in FY2023 (-30.5%), $184.16 million in FY2022 (-24.0%) and $242.39 million in FY2021 (-21.0%).
  • The Q3 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2018.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 24 quarters, with an average decline of 49.7% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Liabilities and Shareholders Equity ranged from 21.0% (Q4 2021) to 75.5% (Q3 2026).
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $22.62 million (Q2 2026), $37.98 million (Q1 2026) and $50.18 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 197.43 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 147.68 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 205.00 Bn
10 NextCure 29.30 Mn -71.08 Mn - 9.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.70 Mn
Jun 30, 2026 22.62 Mn
Mar 31, 2026 37.98 Mn
Dec 31, 2025 50.18 Mn
Sep 30, 2025 39.61 Mn
Jun 30, 2025 47.69 Mn
Mar 31, 2025 67.14 Mn
Dec 31, 2024 80.86 Mn
Sep 30, 2024 90.35 Mn
Jun 30, 2024 102.59 Mn
Mar 31, 2024 115.16 Mn
Dec 31, 2023 128.04 Mn
Sep 30, 2023 139.94 Mn
Jun 30, 2023 153.38 Mn
Mar 31, 2023 167.79 Mn
Dec 31, 2022 184.16 Mn
Sep 30, 2022 189.91 Mn
Jun 30, 2022 206.37 Mn
Mar 31, 2022 222.75 Mn
Dec 31, 2021 242.39 Mn
API Access

NextCure Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NXTC&period=max&api_key=YOUR_API_KEY